10 Best HealthTech Companies of the Year 2022
Business Fortune
Particular company that will revolutionize healthcare and will pioneer the digital therapeutics realm, especially for people with chronic illnesses. Just two of the many ways Ampersand works with and within the community to discover the future of patient care via technology for better long term health outcomes.
Using Technology to Empower Patients and Clinicians
The great innovative digital platform of Ampersand Health, which links health care practitioners directly with their patients, notably those with chronic conditions like inflammatory bowel disease (IBD) and sickle cell disease, is perhaps embodied in the mission of Ampersand Health. The platform allows for a better quality of care to be given, said the healthcare professionals, through streamlined data collection and remote monitoring and a more personalized approach to the treatment.
In summary, the Ampersand system sees patients receiving much more efficient care, with statistics showing a 34% improvement in disease control and 89% fewer emergency department visits. These statistics reveal how technology may profoundly affect patient results and ease the burden on health care systems.
Touching on Inflammatory Bowel Disease (IBD)
Ampersand Health has improved intervention mainly in chronic conditions with IBD. A study carried out by Hull University Teaching Hospitals studied how Ampersand's patient-facing app could integrate into the IBD care process. A study, which included 594 patients, found hospital routine follow up appointments reduced by 40 percent, and more than half of the flare ups can be managed outside hospital. Digital therapeutics can actually empower patients to manage their condition as well as reallocate healthcare resources.
Thus, the study's findings lend further credence to how much digital health tools could add value in supporting patients at home; fewer hospital visits could mean more insights for clinicians on patient health, and the reduction in costs in-hospital hospitalization.
New Frontier in Digital Therapeutics
Ampersand Health is also pioneering research and development into new solutions for other patients who have complex conditions including neuroendocrine tumors. In addition to that, Ampersand is currently conducting an observational trial together with its co-partners from top hospitals and pharmaceutical companies whereby the use of the mobile app for collecting data on Patient Reported Outcome is looked into and this trial is expected to improve coordination within the clinic and also quality of life for these rare as well as disabling diseases.
On top of that, Ampersand's My Blood app takes away all the worries of most patients with sickle cell disease through its ability to enhance remote care. By upgrading the data collection system, Ampersand helps clinicians make better-informed choices, creating a more effective patient-oriented approach to care.
Digital Health and Its Future
Ampersand Health intends to focus on a new horizon in terms of its business model whereby it is not going to limit itself to only digital tools. It is also keen in redefining the management of long-term health conditions by using technologies to connect people, systems, and process; drive efficiencies; and hence better outcomes for patients, Ampersand sees itself therefore as being part of the revolution in the shift from fee-for-service to value-based care. This progressive mode of thinking brings patients additional benefits in terms of better health when they visit facilities.
With the ongoing advancement of digital therapeutics, Ampersand Health stands ready to continue its role as a significant player in actualizing the new paradigm of healthcare delivery that is itself transforming the outcomes for millions of patients with chronic and complex conditions across the world.
About the Leader
Nader Alaghband, Co-Founder & Chief Executive Officer of Ampersand Health
